Mass vaccination against hepatitis B in infants in Italy.

PubWeight™: 1.33‹?› | Rank: Top 10%

🔗 View Article (PMID 2903337)

Published in Lancet on November 12, 1988

Authors

M Piazza, G Da Villa, L Picciotto, N Abrescia, V Guadagnino, A M Memoli, A Vegnente, R Iorio, L Cimmino

Articles by these authors

Peers, schools, and adolescent cigarette smoking. J Adolesc Health (2001) 5.11

Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS (1996) 2.41

Long term effect of alpha interferon in children with chronic hepatitis B. Gut (2000) 2.21

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology (1997) 1.96

Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch Intern Med (1997) 1.92

Poor bone quality or hip structure as risk factors affecting survival of total-hip arthroplasty. Lancet (2000) 1.82

Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manage (1998) 1.64

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology (1997) 1.58

Passionate kissing and microlesions of the oral mucosa: possible role in AIDS transmission. JAMA (1989) 1.54

A population based survey of hepatitis B virus infection in a southern Italian town. Ital J Gastroenterol Hepatol (1997) 1.49

Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res (2001) 1.36

Chemotherapy for invasive thymoma. A 13-year experience. Cancer (1991) 1.28

Athletic activity after joint replacement. Am J Sports Med (2001) 1.28

Impact of a clinical pathway and implant standardization on total hip arthroplasty: a clinical and economic study of short-term patient outcome. J Arthroplasty (1998) 1.20

Hepatitis B antigen inhibitor in human faeces and intestinal mucosa. Br Med J (1973) 1.19

Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol (2001) 1.18

Serum vitamin D levels and exercise-induced bronchoconstriction in children with asthma. Eur Respir J (2010) 1.17

Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.15

Distribution of the intestinal factor of normal mice which inactivates murine virus hepatitis. Nature (1965) 1.14

Single Price/Case Price Purchasing in orthopaedic surgery: experience at the Lahey Clinic. J Bone Joint Surg Am (2000) 1.14

Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol (1998) 1.13

Effect on the infectivity of various viruses by the intestinal factor of normal mice which inactivates murine hepatitis virus. Nature (1967) 1.12

Chemotherapy of invasive thymoma. J Clin Oncol (1990) 1.11

Semi-nested PCR for the specific detection of Habronema microstoma or Habronema muscae DNA in horse faeces. Parasitology (2004) 1.11

Risk factors affecting radiological failure of the socket in primary Charnley low friction arthroplasty. A 10- to 20-year followup study. Clin Orthop Relat Res (1994) 1.10

p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer (1997) 1.10

Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J (1997) 1.07

Opportunities for control of hospital costs for total joint arthroplasty after initial cost containment. J Arthroplasty (1998) 1.06

Blood loss in computer-assisted mobile bearing total knee arthroplasty. A comparison of computer-assisted surgery with a conventional technique. Int Orthop (2008) 1.05

Hepatitis B immunisation with a reduced number of doses in newborn babies and children. Lancet (1985) 1.04

Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat (1998) 1.03

Presence of HBsAg in the bile of subjects with acute HBsAg viral hepatitis. Pathol Microbiol (Basel) (1975) 1.03

Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial. Hepatology (1996) 1.03

Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis. Virchows Arch (1994) 1.01

Dark-induced senescence of barley leaves involves activation of plastid transglutaminases. Amino Acids (2015) 1.00

Letter: Hepatitis B not transmissible via faecal-oral route. Lancet (1975) 1.00

Two-dose hepatitis B immunisation regimen for infants. Lancet (1985) 1.00

Prevalence of HNPCC in a series of consecutive patients on the first endoscopic diagnosis of colorectal cancer: a multicenter study. The Italian Collaborative Group. Endoscopy (1999) 0.98

Letter: Fulminant viral hepatitis. Lancet (1975) 0.97

Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology (1996) 0.96

Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings. Eur J Clin Microbiol Infect Dis (2001) 0.96

Infection with the delta agent in children. Gut (1985) 0.95

Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol (2003) 0.95

Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J Immunol (1999) 0.95

Jagged-1 mutation analysis in Italian Alagille syndrome patients. Hum Mutat (1999) 0.94

Opportunities for control of hospital cost for total knee arthroplasty. Clin Orthop Relat Res (1997) 0.94

Trabecular minimodeling in human iliac bone. Bone (2003) 0.94

Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. Hepatology (1996) 0.93

Medial reconstruction during total knee arthroplasty for severe valgus deformity. Clin Orthop Relat Res (1998) 0.93

Role of the genetic study in the management of carotid body tumor in paraganglioma syndrome. Eur J Vasc Endovasc Surg (2008) 0.92

Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. Eur J Neurol (2009) 0.92

Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART. J Acquir Immune Defic Syndr (2001) 0.92

Athletic activity after total knee arthroplasty. Clin Orthop Relat Res (2000) 0.92

Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. J Interferon Cytokine Res (2001) 0.91

Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy. Infection (2006) 0.91

Scoliosis surgery in neurofibromatosis. Clin Orthop Relat Res (1989) 0.90

Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town. Infection (2011) 0.90

Spontaneous bacterial peritonitis in children with chronic liver disease: clinical features and etiologic factors. J Pediatr (1985) 0.90

Macroenzyme investigation and monitoring in children with persistent increase of aspartate aminotransferase of unexplained origin. J Pediatr (1998) 0.90

Injury survey in competitive sub-elite rhythmic gymnasts: results from a prospective controlled study. J Sports Med Phys Fitness (2007) 0.90

Quality of life assessment in HIV-positive persons: application and validation of the WHOQOL-HIV, Italian version. AIDS Care (2002) 0.88

Contamination by hepatitis B surface antigen in dental surgeries. Br Med J (Clin Res Ed) (1987) 0.88

[A familial outbreak of adenovirus type 21 infection (follicular conjunctivitis)]. Riv Ist Sieroter Ital (1969) 0.88

Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol (2003) 0.88

Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Vaccine (1999) 0.88

The fate of murine hepatitis virus (MHV-3) after intravenous injection into susceptible mice. Arch Gesamte Virusforsch (1967) 0.87

A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. J Viral Hepat (2005) 0.87

A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided? Acta Diabetol (2007) 0.87

Implantation of parotid pleomorphic adenoma in the upper neck. ORL J Otorhinolaryngol Relat Spec (1991) 0.87

Blood in saliva of patients with acquired immunodeficiency syndrome: possible implication in sexual transmission of the disease. J Med Virol (1994) 0.87

Low back pain in competitive rhythmic gymnasts. J Sports Med Phys Fitness (2004) 0.86

A lateral minimal-incision technique in total hip replacement: a prospective, randomizes, controlled trial. Hip Int (2009) 0.86

Risk of hepatitis B virus infection in patients with eczema or psoriasis of the hand. Br Med J (Clin Res Ed) (1982) 0.86

Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection. Pediatr Infect Dis J (1996) 0.86

Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clin Chem (2001) 0.86

Leaping ability and body composition in rhythmic gymnasts for talent identification. J Sports Med Phys Fitness (2008) 0.85